|
TERRY COELHO - DIRECTOR |
Ms. Coelho joined our board of directors in August 2021. She currently serves as the Chief Financial Officer for Gamida Cell Ltd. She previously served as the Executive Vice President, Chief Financial Officer & Chief Business Development Officer of CinCor Pharma, Inc. a clinical stage cardiorenal therapeutics company, having led the company through its IPO in early 2022 and the preparation for its eventual sale to AstraZeneca. Previously, Ms. Coelho served as Executive Vice President and Chief Financial Officer at BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a commercial-stage specialty pharmaceutical company, from January 2019 to November 2021. Prior to her tenure at BDSI, Ms. Coelho served as Chief Financial Officer and Treasurer at Balchem Corporation (NASDAQ: BCPC) and Chief Operating Officer for Diversey, Inc., a multi-billion-dollar global private equity carve-out from Sealed Air Corporation. She additionally held senior finance positions at Diversey Care, including that of Division Chief Financial Officer and VP of Global Commercial Excellence, from October 2014 through August 2017. Ms. Coelho has also served in senior finance and operational leadership roles of increasing responsibility with leading global organizations, including Mars, Incorporated for 20 years, and Novartis Pharmaceuticals from 2007 to 2014, including serving as Global Head of Oncology Development Finance. Ms. Coelho currently also serves on the Board of Directors of HOOKIPA Pharma and the Board of Directors of Inotiv, Inc.. Ms. Coelho earned an MBA in Finance from IBMEC in Brazil and a Bachelor of Arts degree in both Economics and International Relations, summa cum laude, from The American University School of International Service in Washington, DC. She has led Women’s Networking ERGs at several companies and is a founding Steering Committee Member of the CFO Leadership Council – Charlotte, North Carolina, chapter. |